GlassScriptPhysician profile
Rodney D Henderson
NPI 1225035488
$222,298.73
in general payments reported to CMS, 2019-2025
14 companies · $16K in 2025
The $16K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49K · 2020: $87K · 2021: $18K · 2022: $25K · 2023: $9,169 · 2024: $18K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $37K · Consulting Fee: $7,013 · Food and Beverage: $68.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $36,950.87 |
| Consulting Fee | $7,012.50 |
| Food and Beverage | $68.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $144,501.07 | 2019-2025 | Djo Surgical |
| Stryker Corporation | $70,018.62 | 2019-2020 | |
| Conformis, INC. | $6,903.69 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $450.00 | 2019 | |
| Smith+Nephew, INC. | $113.89 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $68.37 | 2024-2025 | |
| Medacta USA, INC. | $47.37 | 2020 | |
| Team_makena_llc | $44.77 | 2020 | |
| Fidia Pharma USA INC. | $36.79 | 2019 | |
| Linvatec Corporation | $30.49 | 2020 | |
| Ethicon US, LLC | $28.98 | 2021 | |
| Wright Medical Technology, INC. | $25.41 | 2019 | |
| Microport Orthopedics INC | $17.91 | 2020 | |
| Abbvie INC. | $11.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Henderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.